FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8  |  FHIR Version n/a  User: [n/a]

32963411000001107: Uptravi 200microgram tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1389081000001119 Uptravi 200microgram tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1389091000001117 Uptravi 200microgram tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100462901000001111 Uptravi 200microgram tablets (Actelion Pharmaceuticals UK Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
100463001000001119 Uptravi 200microgram tablets (Actelion Pharmaceuticals UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Is a Selexipag 200microgram tablets true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient Selexipag false Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Is a Uptravi true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has active ingredient Vasodilator false Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient Selexipag true Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 10 tablet Has AMP True Uptravi 200microgram tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 60 tablet Has AMP True Uptravi 200microgram tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 140 tablet Has AMP True Uptravi 200microgram tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start